Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2024, Vol. 20 ›› Issue (06): 635 -643. doi: 10.3877/cma.j.issn.1673-5250.2024.06.007

Original Article

Clinical treatment and prognosis of systemic lupus erythematosus-related acute pancreatitis in children

Jiayi Lu1, Fei Tang1, Fen Lu1, Yuhong Tao1,()   

  1. 1. Department of Pediatric Nephrology,Key Laboratory of Birth Defects and Related Diseases of Women and Children(Sichuan University),Ministry of Education,West China Second University Hospital,Sichuan University,Chengdu 610041,Sichuan Province,China
  • Received:2024-11-05 Revised:2024-11-20 Published:2024-12-01
  • Corresponding author: Yuhong Tao

Objective

To explore the clinical diagnosis,treatment and prognosis of systemic lupus erythematosus (SLE)-related acute pancreatitis(AP)in children.

Methods

Twenty-four children with SLE-related AP admitted to West China Second University Hospital,Sichuan University from January 2018 to December 2024 were selected as the research subjects.AP was the initial presentation in 7 patients,and 17 patients were complicated by AP after the diagnosis of SLE.A retrospective study method was used to collect the general clinical data,clinical symptoms and signs,laboratory tests,imaging examinations,SLE disease activity index (SLEDAI),treatment and prognosis of all children.The procedures followed in this study were in line with the requirements of the newly revised World Medical Association Declaration of Helsinki in 2024.

Results

The results of clinical diagnosis,treatment and prognosis analysis of 24 children in this study were as follows.①General clinical data:Among the 24 cases of SLE-related AP children,the median age of SLE diagnosis was 12 years old,and there were 22 females (91.7%).Severe AP accounted for 54.2%(13/24).Common gastrointestinal manifestations included abdominal pain in 21 cases(87.5%),nausea and vomiting in 17 cases (70.8%),abdominal distension in 11 cases (45.8%),and upper abdominal tenderness in 19 cases (79.2%).The SLEDAI score was 16-41 points.All had≥2 organs/systems involved,with acute kidney injury(AKI)in 16 cases (66.7%)and macrophage activation syndrome(MAS)in 4 cases (16.7%).②Results of auxiliary examinations:Among the 24 cases of SLE-related AP children,the proportions of elevated serum amylase and(or)lipase,decreased serum Ca2+concentration,elevated triglyceride concentration were 20 cases(83.3%),22 cases(91.7%)and 20 cases (95.2%,20/21),respectively.Abnormal abdominal CT results were found in 20 children (83.3%).Abdominal ultrasound was performed in 17 children,and abnormalities were found in 7 children (41.2%).④Treatment and outcome:All 24 children received high-dose methylprednisolone pulse therapy,21 children were given immunosuppressants,and 18 children received plasma exchange therapy.After treatment,18 children (75.0%)achieved clinical remission and were discharged,six children (25.0%)died,all of whom were severe AP.The mortality rate of children with severe AP was 46.2%(6/13).

Conclusions

Children with SLE-related AP has a similar clinical manifestation to AP children without SLE and occurs mostly in adolescent females,all of whom have active SLE with multiple organ system involvement.SLE-related severe AP is relatively common and has a high mortality rate.High-dose glucocorticoid therapy combined with immunosuppression and plasma exchange may lead to a better prognosis in children with SLErelated AP.

表1 本研究24例SLE相关性AP患儿相关临床资料比较
患儿编号 年龄(岁)/性别/SLE病程(月) AP分度/SLEDAI评分(分)/合并MAS 腹痛/呕吐/腹泻/腹胀/上腹压痛/反跳痛/移动性浊音 合并其他疾病情况
1 9/女/0.5 轻症/23/否 +/-/-/-/+/+/- 神经精神性狼疮、狼疮性肺炎、狼疮性肾炎、贫血、血小板减少
2 13/女/0 重症/22/否 +/+/-/-/-/-/- 狼疮性肾炎、凝血功能障碍、继发性甲状腺功能亢进
3 11/女/0 重症/20/否 +/+/+/+/+/-/+ 狼疮性肺炎、呼吸衰竭、心包炎、狼疮性肾炎
4 6/女/2 重症/41/否 +/+/+/+/-/-/- 神经精神性狼疮、呼吸衰竭、心肌炎、心力衰竭、狼疮性肝炎、狼疮性肾炎、自身免疫性溶血性贫血、继发性甲状腺功能减退
5 11/女/0 重症/30/是 +/+/+/+/+/+/- 呼吸衰竭、心力衰竭、狼疮性肾炎
6 13/女/0 重症/16/否 +/+/-/-/+/-/- 狼疮性肾炎、贫血
7 10/女/1 轻症/31/否 +/-/-/+/+/-/- 神经精神性狼疮、狼疮性肺炎、狼疮性肝炎、狼疮性肾炎
8 13/女/0 重症/17/否 +/+/-/-/+/+/- 呼吸衰竭、心肌炎、凝血功能障碍、自身免疫性溶血性贫血、继发性糖尿病、继发性甲状腺功能减退
9 11/女/0 轻症/23/否 +/+/-/+/+/-/- 狼疮性肺炎、心肌炎、狼疮性肾炎、自身免疫性溶血性贫血、继发性甲状腺功能减退
10 13/女/0 轻症/24/否 +/-/-/-/+/+/- 心肌炎、狼疮性肾炎、急性腹膜炎、溶血性贫血
11 14/女/0.5 重症/32/是 +/+/+/+/+/-/- 神经精神性狼疮、呼吸衰竭、狼疮性肝炎、弥漫性凝血功能障碍
12 15/女/48 轻症/23/否 +/+/-/+/+/-/- 狼疮性肺炎、狼疮性肾炎
13 13/女/1 重症/28/是 +/+/+/+/+/-/+ 神经精神性狼疮、呼吸衰竭、心肌炎、狼疮性肝炎、狼疮性肾炎、弥漫性凝血功能障碍
14 9/女/1 轻症/24/否 +/+/-/-/+/-/- 神经精神性狼疮、狼疮性肺炎、心肌炎、狼疮性肾炎、凝血功能障碍
15 14/女/1 重症/22/否 +/-/-/-/+/+/- 神经精神性狼疮、狼疮性肺炎、心肌炎、心力衰竭、狼疮性肝炎、狼疮性肾炎、凝血功能障碍、慢性淋巴细胞性甲状腺炎
16 16/女/60 轻症/20/否 -/+/-/+/+/-/- 狼疮性肾炎、凝血功能障碍
17 10/女/0.7 轻症/19/否 -/-/-/-/-/-/- 神经精神性狼疮、狼疮性肾炎、贫血、眼底病变、继发性甲状腺功能减退
18 10/女/0.3 重症/24/否 -/-/-/-/-/-/- 狼疮性肺炎、心肌炎
19 10/女/1 重症/19/是 -/+/-/-/-/-/- 神经精神性狼疮、狼疮性肺炎、心肌炎、狼疮性肾炎、凝血功能障碍
20 14/女/12 轻症/16/否 +/-/-/+/+/-/- 神经精神性狼疮、狼疮性肾炎、凝血功能障碍、关节炎
21 13/女/18 重症/18/否 +/+/-/+/+/-/- 神经精神系统狼疮、肺出血、心肌炎、狼疮性肝炎、贫血、凝血功能障碍、继发性甲状腺功能减退
22 10/男/1 重症/20/否 +/+/+/-/+/-/- 狼疮性肝炎、狼疮性肾炎
23 15/女/3 轻症/20/否 +/+/-/-/+/-/- 狼疮性肺炎、心包炎、凝血功能障碍、继发性甲状腺功能减退
24 10/男/11 轻症/22/否 +/+/-/-/+/-/- 神经精神性狼疮、狼疮性肝炎、狼疮性肾炎、凝血功能障碍
表2 24例SLE相关性AP患儿主要辅助检查结果比较
患儿编号 ANA 抗dsDNA抗体(RU/mL)/抗Sm 抗体(RU/mL) ANCA 血淀粉酶升高(倍数)/血脂肪酶升高(倍数)a 血Ca2+ (mmol/L)/甘油三酯(mmol/L)/血肌酐(μmol/L) 腹部超声 腹部CT
1 1∶3 200 278.0/4.5 阳性 1.40/<1.00 2.17/5.79/174 胰腺增大,回声改变 胰腺增大,周周有渗出
2 1∶320 2.8/1.4 7.71/6.61 1.23/—/836 胰腺增大
3 1∶320 15.6/2.5 阴性 1.56/<1.00 1.78/2.60/103 未见异常 胰腺边缘模糊
4 阴性 0.2/0.8 阴性 13.47/2.60 2.05/2.62/238 胰腺增大 胰腺周围有渗出
5 1∶1 000 68.0/0.7 可疑阳性 1.76/1.96 1.77/2.84/114 未见异常 胰腺边缘模糊
6 1∶320 5.9/0.1 可疑阳性 1.21/1.83 2.00/1.09/88 腹腔脂肪间隙模糊
7 >1∶3 200 28.5/1.5 阴性 <1.00/<1.00 2.20/2.19/49 胰腺增大 胰腺体尾部饱满
8 1∶320 0.4/0.5 阴性 5.51/10.80 1.90/—/46 胰腺增大
9 1∶3 200 5.7/9.2 阴性 2.06/5.93 1.80/5.89/100 未见异常 胰腺饱满,周围有渗出
10 1∶3 200 382.7/7.3 2.51/3.71 1.98/6.05/183 未见异常 未见异常
11 1∶3 200 1.7/8.2 阳性 3.64/9.15 1.61/—/231 胰腺增大,回声改变 胰腺增大,周围有渗出
12 1∶1 000 221.5/3.6 <1.00/<1.00 1.74/2.21/131 胰腺饱满
13 1∶1 000 48.5/0.7 阳性 2.16/5.50 1.70/>12.44/227 胰腺回声改变 胰腺饱满,周围脂肪间隙模糊
14 1∶1 000 761.2/15.0 阴性 <1.00/<1.00 1.86/2.77/47 未见异常
15 >1∶3 200 512.5/>400.0 阴性 30.15/65.30 0.24/11.71/97 胰腺增大 胰腺增大,周围有渗出
16 1∶320 17.8/0.8 可疑阳性 <1.00/1.43 1.76/2.84/284 未见异常 胰腺饱满,周围脂肪密度稍增高
17 1∶1 000 4.9/40.2 阴性 <1.00/1.20 1.98/1.23/36 未见异常 胰腺饱满
18 1∶3 200 4.5/127.4 阴性 1.09/3.64 1.65/1.57/26 未见异常 未见异常
19 1∶3 200 3.6/1.7 3.39/9.45 1.93/4.25/162 未见异常 胰腺未见异常
20 1∶320 5.4/194.0 阴性 1.17/3.01 1.86/1.50/30 未见异常 胰腺饱满,周围有渗出,脂肪间隙密度高
21 1∶1 000 3.1/1.1 1.30/<1.00 1.61/6.75/201 胰腺增大 腹腔脂肪间隙模糊
22 1∶320 17.0/0.9 阴性 4.50/4.80 1.79/5.09/237 胰腺周围有渗出,脂肪间隙模糊
23 1∶1 000 >500.0/<0.5 阳性 1.33/4.77 1.73/4.05/241 未见异常 未见异常
24 1∶320 231.3/62.4 阴性 <1.00/<1.00 2.01/3.16/38 胆总管胰腺段扩张
续表3
患儿编号 MP冲击治疗 免疫抑制剂 血浆置换(次) 血液透析(次) CRRT(次) IVIG冲击治疗 治疗药物 转归 随访时间(月)
1 CTX冲击 7 8 0 美罗培南、头孢曲松、青霉素、头孢硫脒、氟康唑 好转出院 70
2 MMF 0 13 5 哌拉西林他唑巴坦、头孢哌酮他唑巴坦 好转出院 10
3 CTX冲击 3 8 0 头孢曲松、头孢哌酮舒巴坦、美罗培南、伏立康唑、氟康唑 死亡 /
4 CTX冲击 7 0 25 亚胺培南、左氧氟沙星、美罗培南、伏立康唑、米卡芬净钠 死亡 /
5 5 11 2 头孢哌酮舒巴坦、美罗培南、氟康唑 死亡 /
患儿编号 MP冲击治疗 免疫抑制剂 血浆置换(次) 血液透析(次) CRRT(次) IVIG冲击治疗 治疗药物 转归 随访时间(月)
6 CTX冲击 3 0 0 阿莫西林克拉维酸钾、阿奇霉素 好转出院 33
7 CsA 5 0 0 美洛西林、头孢哌酮舒巴坦、阿奇霉素 好转出院 38
8 MMF 0 0 0 亚胺培南西司他丁钠、万古霉素、阿奇霉素、伏立康唑 好转出院 4
9 CTX冲击 5 0 0 头孢哌酮钠舒巴坦钠、阿奇霉素、氟康唑 好转出院 48
10 CTX冲击 4 0 0 头孢哌酮舒巴坦 好转出院 10
11 CTX冲击 6 2 7 美罗培南、哌拉西林他唑巴坦、头孢哌酮钠舒巴坦钠、替加环素、利奈唑胺、米卡芬净钠、磺胺 死亡 /
12 MMF 0 0 0 阿莫西林克拉维酸钾、阿奇霉素 好转出院 2
13 CTX冲击 5 8 25 头孢他啶、头孢哌酮舒巴坦、亚胺培南、利奈唑胺、哌拉西林他唑巴坦、伏立康唑 好转出院 36
14 0 0 0 哌拉西林他唑巴坦 好转出院 45
15 0 0 2 哌拉西林他唑巴坦、亚胺培南、利奈唑胺、米卡芬净钠、替加环素 死亡 /
16 MMF 3 13 0 头孢他啶 好转出院 24
17 CTX冲击 5 0 0 氟康唑、哌拉西林钠他唑巴坦钠 好转出院 32
18 CTX冲击 5 0 0 头孢他啶、氟康唑、伏立康唑 好转出院 27
19 CsA+CTX冲击 9 11 5 利奈唑胺、美罗培南、头孢哌酮舒巴坦、磺胺甲噁唑、米卡芬净钠、阿莫西林 死亡 /
20 MMF+CTX冲击 0 0 0 头孢曲松、头孢哌酮舒巴坦钠 好转出院 24
21 MMF+Tac 3 16 8 头孢曲松、头孢哌酮舒巴坦、美罗培南、万古霉素、伏立康唑、磺胺甲噁唑 好转出院 22
22 MMF 5 2 4 头孢哌酮舒巴坦、美罗培南、利奈唑胺、磺胺、伏立康唑 好转出院 14
23 MMF 2 1 3 头孢曲松、头孢哌酮舒巴坦、美罗培南 好转出院 10
24 MMF 3 0 0 头孢曲松、头孢哌酮舒巴坦、氟康唑 好转出院 6
[1]
Myung DS,Kim TJ,Lee SJ,et al.Lupus-associated pancreatitis complicated by pancreatic pseudocyst and central nervous system vasculitis[J].Lupus,2009,18(1):74-77.DOI:10.1177/0961203308093462.
[2]
Breuer GS,Baer A,Dahan D,et al.Lupus-associated pancreatitis[J].Autoimmun Rev,2006,5(5):314-318.DOI:10.1016/j.autrev.2005.11.004.
[3]
Williamson L,Hao Y,Basnayake C,et al.Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus[J].Semin Arthritis Rheum,2024,69:152567.DOI:10.1016/j.semarthrit.2024.152567.
[4]
Lin Q,Zhang M,Tang H,et al.Acute pancreatitis and macrophage activation syndrome in pediatric systemic lupus erythematosus:case-based review[J].Rheumatol Int,2020,40(5):811-819.DOI:10.1007/s00296-019-04388-4.
[5]
Stevic M,Budic I,Ristic N,et al.Toxic epidermal necrolysis in a child with lupus-associated pancreatitis[J].Rheumatol Int,2017,37(7):1221-1226.DOI:10.1007/s00296-017-3677-6.
[6]
舒静, 甄小芳, 何强, 等.儿童系统性红斑狼疮合并急性胰腺炎1例及文献复习[J].中国医刊,2019,54(8):903-906.DOI:10.3969/j.issn.1008-1070.2019.08.027.Shu J,Zhen XF,He Q,et al.A case of systemic lupus erythematosus complicated with acute pancreatitis in children and literature review[J].Chin J Med,2019,54(8) :903-906.DOI:10.3969/j.issn.1008-1070.2019.08.027.
[7]
陈楷柠, 杜悦.以急性胰腺炎为首发症状的儿童系统性红斑狼疮一例[J].中国小儿急救医学,2022,29(11):935-937.DOI:10.3760/cma.j.issn.1673-4912.2022.11.018.Chen KN,Du Y.A case of systemic lupus erythematosus in children with acute pancreatitis as the first symptom[J].Chin Pediatr Emerg Med,2022,29(11):935-937.DOI:10.3760/cma.j.issn.1673-4912.2022.11.018.
[8]
王复娟, 吴小川.儿童狼疮性肾炎并发急性胰腺炎一例[J].国际儿科学杂志,2013,40(3):327-328.DOI:10.3760/cma.j.issn.1673-4408.2013.03.033.Wang FJ,Wu XC.A case of lupus nephritis complicated with acute pancreatitis in children[J].Int J Pediatr,2013,40(3):327-328.DOI:10.3760/cma.j.issn.1673-4408.2013.03.033.
[9]
方优红, 林海华, 楼金玕, 等.12岁女孩反复腹痛、呕吐伴三酰甘油升高、抗核抗体阳性[J].中国当代儿科杂志,2022,24(8):917-922.DOI:10.7499/j.issn.1008-8830.2203006.Fang YH,Lin HH,Lou JG,et al.Recurrent abdominal pain and vomiting with elevated triglyceride and positive antinuclear antibody in a girl aged 12 years[J].Chin J Contemp Pediatr,2022,24(8):917-922.DOI:10.7499/j.issn.1008-8830.2203006.
[10]
Ferjani M,El Euch M,Hammi Y,et al.Systemic lupus erythematosus-related acute pancreatitis:an exceptional form with severe exocrine and endocrine pancreatitic failure in a Tunisian child[J].Clin Case Rep,2022,10(2):e05423.DOI:10.1002/ccr3.5423.
[11]
El Qadiry R,Bourrahouat A,Aitsab I,et al.Systemic lupus erythematosus-related pancreatitis in children:severe and lethal form[J].Case Rep Pediatr,2018,2018:4612754.DOI:10.1155/2018/4612754.
[12]
Marques VL,Gormezano NW,BonfáE,et al.Pancreatitis subtypes survey in 852 childhood-onset systemic lupus erythematosus patients[J].J Pediatr Gastroenterol Nutr,2016,62(2):328-334.DOI:10.1097/MPG.000000000 0000990.
[13]
Richer O,Ulinski T,Lemelle I,et al.Abdominal manifestations in childhood-onset systemic lupus erythematosus[J].Ann Rheum Dis,2007,66(2):174-178.DOI:10.1136/ard.2005.050070.
[14]
Shukla-Udawatta M,Madani S,Kamat D.An update on pediatric pancreatitis[J].Pediatr Ann,2017,46(5):e207-e211.DOI:10.3928/19382359-20170420-01.
[15]
Besma BD,Zohra A,Fatma B,et al.Pancreatitis in systemic lupus erythematosus[J].Tunis Med,2012,90(3):268-270.
[16]
Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40(9):1725.DOI:10.1002/art.1780400928.
[17]
Morinville VD,Husain SZ,Bai H,et al.Definitions of pediatric pancreatitis and survey of present clinical practices[J].J Pediatr Gastroenterol Nutr,2012,55(3):261-265.DOI:10.1097/MPG.0b013e31824f1516.
[18]
Takeda K,Yokoe M,Takada T,et al.Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading[J].J Hepatobiliary Pancreat Sci,2010,17(1):37-44.DOI:10.1007/s00534-009-0213-4.
[19]
高敬岩, 汪朝慧, 傅小云, 等.227例儿童急性胰腺炎的临床特征和预后分析[J].中华危重病急救医学,2024,36(6):630-634.DOI:10.3760/cma.j.cn121430-20240219-00146.Gao JY,Wang CH,Fu XY,et al.Clinical characteristics and prognosis of 227 children with acute pancreatitis[J].Chin Crit Care Med,2024,36(6):630-634.DOI:10.3760/cma.j.cn121430-20240219-00146.
[20]
孙娟, 李明霞, 杜天华, 等.儿童急性胰腺炎临床特征与预后分析[J].中国当代儿科杂志,2023,25(9):947-952.DOI:10.7499/j.issn.1008-8830.2304020.Sun J,Li MX,Du TH,et al.Clinical characteristics and prognosis of children with acute pancreatitis[J].Chin J Contemp Pediatr,2023,25(9):947-952.DOI:10.7499/j.issn.1008-8830.2304020.
[21]
Tian XP,Zhang X.Gastrointestinal involvement in systemic lupus erythematosus:insight into pathogenesis,diagnosis and treatment[J].World J Gastroenterol,2010,16(24):2971-2977.DOI:10.3748/wjg.v16.i24.2971.
[22]
Wang Q,Shen M,Leng X,et al.Prevalence,severity,and clinical features of acute and chronic pancreatitis in patients with systemic lupus erythematosus[J].Rheumatol Int,2016,36(10):1413-1419.DOI:10.1007/s00296-016-3526-z.
[23]
Yang Y,Ye Y,Liang L,et al.Systemic-lupuserythematosus-related acute pancreatitis:a cohort from South China[J].Clin Dev Immunol,2012,2012:568564.DOI:10.1155/2012/568564.
[24]
Dhir V,Misra R,Agarwal V,et al.Lupus pancreatitisearly manifestation of active disease[J].Lupus,2011,20(5):547-548.DOI:10.1177/0961203310385165.
[25]
中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等.儿童系统性红斑狼疮临床诊断与治疗专家共识(2022版)[J].中华实用儿科临床杂志,2022,37(9):641-652.DOI:10.3760/cma.j.cn101070-20220321-00295.The Subspecialty Group of Rheumatology,the Society of Pediatrics,Chinese Medical Association;The Pediatric Group of Chinese Medical Doctor Association Committee on Rheumatology and Immunology;The Pediatric Group of Rheumatology and Immunology Professional Committee of Cross Strait Medical and Health Exchange Association;et al.Expert consensus on clinical diagnosis and treatment of systemic lupus erythematosus in children(2022 edition)[J].Chin J Pract Pediatr,2022,37(9):641-652.DOI:10.3760/cma.j.cn1070-20220321-00295.
[26]
Isenberg DA,Rahman A,Allen E,et al.BILAG 2004.Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus[J].Rheumatology (Oxford),2005,44(7):902-906.DOI:10.1093/rheumatology/keh624.
[27]
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组.2020中国系统性红斑狼疮诊疗指南[J].中华内科杂志,2020,59(3):172-185.DOI:10.3760/cma.j.issn.0578-1426.2020.03.002.Chinese Rheumatology Association,National Clinical Research Center for Dermatologic and Immunologic Diseases,Chinese Systemic Lupus Erythematosus Treatment and Research Group.2020 Chinese systemic lupus erythematosus diagnosis and treatment guidelines[J].Chin J Intern Med,2020,59(3):172-185.DOI:10.3760/cma.j.issn.0578-1426.2020.03.002.
[28]
Dima A,Balaban DV,Jurcut C,et al.Systemic lupus erythematosus-related acute pancreatitis[J].Lupus,2021,30(1):5-14.DOI:10.1177/0961203320978515.
[29]
Sabre A,Guthrie MM,Maleknia R.Acute necrotising pancreatitis derived from low-dose corticosteroid use:an important reminder of clinical management[J].BMJ Case Rep,2015,2015:bcr2015209325.DOI:10.1136/bcr-2015-209325.
[30]
Sadr-Azodi O,Mattsson F,Bexlius TS,et al.Association of oral glucocorticoid use with an increased risk of acute pancreatitis:a population-based nested case-control study[J].JAMA Intern Med,2013,173(6):444-449.DOI:10.1001/jamainternmed.2013.2737.
[31]
中国医师协会儿科医师分会血液净化专业委员会.儿童血浆置换临床应用专家共识[J].中华实用儿科临床杂志,2018,33(15):1128-1135.DOI:10.3760/cma.j.issn.2095-428X.2018.15.003.Blood Purification Specialist Committee of Pediatric Association in Chinese Medical Doctor Association.Expert consensus documents on clinical application of plasma exchange in pediatrics[J].Chin J Pract Pediatr,2018,33(15):1128-1135.DOI:10.3760/cma.j.issn.2095-428X.2018.15.003.
[32]
Yu YK,Yu F,Ye C,et al.Retrospective analysis of plasma exchange combined with glucocorticosteroids for the treatment of systemic lupus erythematosus-related acute pancreatitis in central China[J].J Huazhong Univ Sci Technolog Med Sci,2016,36(4):501-508.DOI:10.1007/s11596-016-1615-6.
[33]
Biesenbach P,Schmaldienst S,Smolen JS,et al.Immunoadsorption in SLE:three different high affinity columns are adequately effective in removing a utoantibodies and controlling disease activity[J].Atheroscler Suppl,2009,10(5):114-121.DOI:10.1016/S1567-5688(09)71824-0.
[34]
Stummvoll GH,Aringer M,Smolen JS,et al.Ig G immunoadsorption reduces systemic lupus erythematosus activity and proteinuria:a long term observational study[J].Ann Rheum Dis,2005,64(7):1015-1021.DOI:10.1136/ard.2004.029660.
[1] Linlin Li, Xue Bai, Haidong Zhao, Xi Liang, Xuelu Li. Application of 21-gene recurrence risk score in early breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2025, 19(01): 33-38.
[2] Zhenning Wang, Kang Yang, Dechen Wang, Min Zou, Mingbin Gui, Yanan Wang, Ming Xu. Short-term efficacy of ghost ileostomy versus loop-type ileostomy following laparoscopic radical resection for rectal cancer: A propensity score matched cohort study[J]. Chinese Archives of General Surgery(Electronic Edition), 2025, 19(01): 21-27.
[3] Baohe Chen, Wenzhuo Zhang, Jun Wang. Clinical observation of proximal and medium-term laparoscopic radical resection of right half colon cancer by combined cephalocaudal approach[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 153-156.
[4] Yang Wei, Yuanquan Zhao, Xiaobo Wang, Hai Huang, Jie Chen. Risk analysis and prediction model establishment of early recurrence in patients with BCLC stage 0/A hepatocellular carcinoma after postoperative adjuvant therapy[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 157-161.
[5] Zheng Li, Jinfeng Ma. Construction of a nomogram model for predicting prognosis of esophagogastric junction adenocarcinoma patients after radical surgery based on inflammatory response scoring system[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 170-175.
[6] Jiaxu Dong, Meizi Song, Xun Bi. Effect and survival prognosis of radiofrequency ablation combined with TSH suppression in the treatment of papillary thyroid microcarcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2025, 19(02): 200-203.
[7] Zhixin Liu, Xiaolin Cheng, Wenjun Xiao, Siqi Liu. Application of day surgery mode in laparoscopy for hydrocele in children[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(01): 36-40.
[8] Miao Sun, Shengde Wu. Robot-assisted technology for treating pediatric hydronephrosis:a scope review[J]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(01): 95-102.
[9] Kuilin Lyu, Hong Chen. Analysis of epidemiological and clinical characteristics of 465 pediatric cases of Mycoplasma pneumoniae pneumonia: a single-center retrospective study[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 55-61.
[10] Qiang Feng, Shanshan Tong, Xueling Wu, Min Cui. Analysis of adverse reactions of eosinophilia in perinatal women with pulmonary embolism induced by nadroparin[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2025, 18(01): 86-91.
[11] Bing Zeng, Jinhong Li, Haiyang Xin, Fuheng Liu, Zhilong Yuan, Wenchang Gan, Canfeng Cai, Yingru Li. Expression and clinical significance of KDM4C in colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2025, 14(01): 53-61.
[12] Yue Wang, Heng Lu, Jie Cao, Bowen Lu. Expression of GNG4 protein and its prognostic significance in gastrointestinal stromal tumors[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(01): 6-10.
[13] Hongying Zhao, Rongke Jiang, Yu Wang, Mei Zhu, Yanfang Li. Study on the key technology application of CEACAM19 gene in the pathogenesis and prognosis judgment of gastric cancer by regulating PI3K/AKT signaling pathway[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(01): 16-22.
[14] Hongliang Duan, Hongmei Zhao, Tao Li, Jianfeng Xin. Relationship between SPOCD1 expression and clinicopathological features, postoperative recurrence and metastasis in colorectal cancer[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(01): 40-45.
[15] Caiyun Han, Jiao Ma, Yan Li. Study on the correlation between serum PAF and sTM levels and rotavirus enteritis and dehydration degree in children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2025, 15(01): 83-88.
Viewed
Full text


Abstract